The number of people with susceptibility test result for rifampicin in Denmark
Denmark: The number of people with susceptibility test result for rifampicin was 113 in 2021. ▼ Falling
Latest (2021)
113
Change on year
down 11.7%
World rank
106th
of 155 countries
All-time high
171
in 2019
All-time low
113
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Denmark, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Denmark stood at 113. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 11.7% on the previous year and down 27.1% over five years.
That places Denmark 106th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Denmark, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 155 | — |
| 2018 | 160 | +3.2% |
| 2019 | 171 | +6.9% |
| 2020 | 128 | -25.1% |
| 2021 | 113 | -11.7% |
Denmark compared with similar countries
- Denmark's 113 is below the median for high income countries, which is 142, 80% of the median. (61 countries reporting)
- Denmark's 113 is below the median for Europe & Central Asia, which is 229.5, 49% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 162 | 155 | 171 | 3 |
| 2020s | 120.5 | 113 | 128 | 2 |
Countries ranked near Denmark
More health data for Denmark
- Un projection of annual infant deaths, annual growth rate -3.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1019 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4524 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0247 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.4338 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Denmark?
- The number of people with susceptibility test result for rifampicin in Denmark was 113 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Denmark?
- The highest recorded value was 171 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Denmark?
- The lowest recorded value was 113 in 2021.
- How does Denmark rank for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 106th out of 155 countries with data for 2021.
- Where does this Denmark data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).